Systematic Review of Recommendations on the Use of Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Cancer.
Maria Angeles Lopez-OlivoGregory PrattAliza R Karpes MatusevichSusan Ruyu QiNatalia V ZamoraRobin SharmaGregory PrattMaria E Suarez-AlmazorPublished in: Arthritis care & research (2020)
Recommendations for the treatment of RA in patients with cancer often fail to meet expected methodologic criteria. There was agreement on the need for caution when prescribing DMARDs to these patients. However, several areas continue to lack consensus, and given the paucity of evidence, there is an urgent need for research and expert opinion to guide and standardize the management of RA in patients with cancer.
Keyphrases
- systematic review
- rheumatoid arthritis
- clinical practice
- end stage renal disease
- ejection fraction
- primary care
- chronic kidney disease
- newly diagnosed
- disease activity
- rheumatoid arthritis patients
- ankylosing spondylitis
- meta analyses
- squamous cell carcinoma
- prognostic factors
- squamous cell
- systemic sclerosis
- young adults
- idiopathic pulmonary fibrosis
- childhood cancer